Hemangiomas: An Overview

Abstract

Get full access to this article

View all access options for this article.

References

Mulliken JB Vascular birthmarks in folklore, history, art, and literature. In Mulliken JB , Young AE , eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company; 1988:3-23.

Drolet BA , Esterly NB , Frieden IJ Hemangiomas in children. N Engl J Med. 1999 ;341:173-181.

Robertson RL , Robson CD , Barnes PD , et al. Head and neck vascular anomalies of childhood. Neuroimaging Clin North Am. 1999;9:115-132.

Pratt AG Birthmarks in infants. Arch Dermatol. 1953 ;67:302-305.

Jacobs AH , Walton RG The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218-222.

Bivings L. Spontaneous regression of angiomas in children. J Pediatr. 1954;45:643-647.

Jacobs AH Strawberry hemangioma: the natural history of the untreated lesion. Calif Med. 1957;86:8-10.

Amir J. , Metzker A. , Krikler R. , et al. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986;3:331-332.

Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatrica. 1955;44:370-379.

10.

Osburn K. , Schosser RH , Everett MA Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol. 1987;16:788-791.

11.

Bowers RE , Graham EA , Tomlinson KM The natural history of the strawberry nevus. Arch Dermatol. 1969;82:667-680.

12.

Margileth AM , Museles M. Cutaneous hemangiomas in children. JAMA. 1965;194:523-526.

13.

Enjolras O. , Mulliken JB The current management of vascular birthmarks . Pediatr Dermatol. 1993;10:311-333.

14.

Finn MC , Glowacki J. , Mulliken JB Congenital vascular lesions: clinical application of a new classification . J Pediatr Surg. 1983;18:894-900.

15.

Burton BK , Schulz CJ , Angle F. , et al. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn. 1995;15: 209-214.

16.

Mueller BU , Mulliken JB The infant with a vascular tumor. Semin Perinatol. 1999;20:332-340.

17.

Blei F. , Walter J. , Orlow SJ , et al. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol. 1998;134:718-722.

18.

Cheung DS , Warman ML , Mulliken JB Hemangioma in twins. Ann Plast Surg. 1997;38:269-274.

19.

Pack GT , Miller TR Hemangiomas: classification, diagnosis, and treatment. Angiology . 1950; 1:405-426.

20.

Malan, E. Vascular Malformations (Angiodysplasias). Milan, Italy: Carlo Erba Foundation; 1974:38-41.

21.

Folkman J. , Klagsbrun M. Angiogenic factors. Science. 1987;235:442-447.

22.

Mulliken JB , Young AE Diagnosis and natural history of hemangiomas. In: Mulliken JB , Young AE , eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company; 1988:41-46.

23.

Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.

24.

Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr. 1999;1 1:457-463.

25.

Sasaki GH , Pang CY , Wittliff JL Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects. Plast Reconstr Surg. 1984;73:359-368.

26.

Xiao X. , Hong L. , Sheng M. Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro. J Pediatr Surg. 1999;34:1603-1605.

27.

Mulliken JB Cutaneous vascular anomalies. In: McCarthy JG , ed. Plastic Surgery. Philadelphia, Pa: WB Saunders Company; 1990:3191-3274.

28.

Mulliken JB , Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics . Plast Reconstr Surg. 1982;69:412-420.

29.

Finn MC , Glowacki J. , Mulliken JB Congenital vascular lesions: clinical application of a new classification . J Pediatr Surg. 1983;18:894-900.

30.

Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol. 1997;24:701-710.

31.

Burrows PE , Laor T. , Paltiel H. , Robertson RL Diagnostic imaging in the evaluation of vascular birthmarks. Derm Clin. 1998;16:455-488.

32.

Kenkel JM , Burns AJ

Vascular anomalies, lasers, and lymphedema (overview). Select Read Plast

Surg. 1995; 8:1-47.

33.

Payne MM , Moyer F. , Marcks KM , Trevaskis AE The precursor to the hemangioma. Plast Reconstr Surg. 1966;38:64-67.

34.

Hidano A. , Nakajima S. Earliest features of the strawberry mark in the newborn. Br J Derm. 1972;87:138-144.

35.

Pasyk KA , Cherry GW , Grabb WC , Sasaki GH Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plast Reconstr Surg. 1984;73:69-77.

36.

Lister WA The natural history of strawberry nevi. Lancet. 1938;1:1429-1434.

37.

Simpson JR Natural history of cavernous haemangiomata. Lancet. 1959;2:1057-1059.

38.

Boon LM , Enjolras O. , Mulliken JB Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996;128:329-335.

39.

Mulliken JB Pathogenesis of hemangiomas. In: Mulliken JB , Young AE , eds. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia, Pa: WB Saunders Company; 1988:63-76.

40.

Glowacki J. , Mulliken JB Mast cells in hemangiomas and vascular malformations . Pediatrics. 1981;70:48-51.

41.

Enjolras O. , Mulliken JB

Vascular tumors and vascular malformations (new issues). Adv

Dermatol. 1998;13:375-423.

42.

Enjolras O.

Vascular tumors and vascular malformations: are we at the dawn of a better knowledge?

Pediatr Dermatol. 1999;16:238-241.

43.

Blei F. New clinical observations in hemangiomas. Sem Cut Med Surg. 1999;18:187-194.

44.

Vikkula M. , Boon LM , Mulliken JB , et al. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998;8:281-292.

45.

Takahashi K. , Mulliken JB , Kozakewich Hpw , et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.

46.

Chang J. , Most D. , Bresnick S. , et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg. 1999 ;103:1-9.

47.

Kraling BM , Razon MJ , Boon LM , et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Path. 1996;148:1181-1191.

48.

Isik FF , Rand RP , Gruss JS , Benjamin D. , et al. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res. 1996 ;61:71-76.

49.

Jang Y-C. , Arumugam S. , Ferguson M. , et al. Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res. 1998;80:9-15.

50.

Razon MJ , Kraling BM , Mulliken JB , et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998;5:189-195.

51.

Mancini AJ , Smoller BR Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopath. 1996;18:505-514.

52.

Martinez-Perez D. , Fein NA , Boon LM , et al. Not all hemangiomas look like strawberries: uncommon presentations of the most common tumor of infancy. Pediatr Dermatol. 1995;12:1-6.

53.

Burrows PE , Mulliken JB , Fellows KE , et al. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol. 1983 ; 141: 483-488.

54.

Yang WT , Ahuja A. , Metreweli C. Sonographic features of head and neck hemangiomas and vascular malformations: review of 23 patients. J Ultrasound Med. 1997 ;16:39-44.

55.

Dubois J. , Garel L. , Grignon A. , et al. Imaging of hemangiomas and vascular malformations in children . Acad Radiol. 1998;5:390-400.

56.

Dubois J. , Patriquin HB , Garel L. , et al. Soft-tissue hemangiomas in infants and children: diagnosis using doppler sonography. AJR Am J Roentgenol. 1998 ;171: 247-252.

57.

Robertson RL , Robson CD , Barnes PD , et al. Head and neck vascular anomalies of childhood. Neuroimaging Clin North Am. 1999;9:115-132.

58.

Meyer JS , Hoffer FA , Barnes PD , et al. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol. 1991;157:559-564.

59.

Enjolras O. , Riche MC , Merland JJ , et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990;85:491-498.

60.

Management of hemangiomas. Pediatr Dermatol. 1997; 14:57-83.

61.

Garden JM , Bakus AD Laser treatment of port-wine stains and hemangiomas. Dermatol Clin. 1997;15:373-383.

62.

Haik GR , Jakobiec FA , Ellsworth RM , et al. Capillary hemangioma of the lids and orbit. An analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology . 1979;86:760-789.

63.

Stigmar G. , Crawford JS , Ward CM , et al. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol. 1978;85:806-813.

64.

Goldberg NS , Rosanova MA Periorbital hemangiomas. Dermatol Clin. 1992;10:653-661.

65.

Orlow SJ , Isakoff MS , Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131:643-646.

66.

Brown TJ , Friedman J. , Levy ML The diagnosis and treatment of common birthmarks. Clin Plast Surg. 1998;25:509-525.

67.

Van Den Abbeele T. , Triglia JM , Lescanne E. , et al. Surgical removal of subglottic hemangiomas in children. Laryngoscope. 1999;109:1281-1286.

68.

Vin-Christian K. , McCalmont TH , Frieden IJ Kaposiform hemangioendothelioma—an aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Arch Dermatol. 1997;133:1573-1578.

69.

Enjolras O. , Wassef M. , Mazoyer E. , et al. Infants with Kasabach-Merritt syndrome do no have “true” hemangiomas. J Pediatr. 1997;130:631-640.

70.

Sarkar M. , Mulliken JB , Kozakewich Hpw , et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-1386.

71.

Reese V. , Frieden IJ , Paller AS , et al. Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr. 1993;122:379-383.

72.

Frieden IJ , Reese V. , Cohen D. PHACE syndrome—the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996 ;132:307-311.

73.

Albright AL , Gartner JC , Wiener ES Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics. 1988 ;83:977-980.

74.

Goldberg NS , Hebert AA , Esterly NB Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol. 1986;22:684-687.

75.

Ezekowitz Rab.

The relationship between facial and airway hemangiomas: does seeing red bode ill?

J Pediatr. 1997;131:514-515.

76.

Pfeiffer N. Guidelines for treating different stages of hemangioma. J Clin Laser Med Surg. 1994;12:239-240.

77.

Frieden IJ , Eichenfield LF , Esterly NB , et al. Guidelines for care of hemangiomas of infancy. J Am Acad Dermatol. 1997;37:631-637.

78.

Frieden IJ

Which hemangiomas to treat-and how?

Arch Dermatol. 1997;133:1593-1595.

79.

Achauer BM , Chang C-J. , Vander Kam VM. Management of hemangioma of infancy: review of 245 patients . Plast Reconstr Surg. 1997;99:1301-1308.

80.

Jackson IT , Carreno R. , Potparic Z. , et al. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993;91:1216-1230.

81.

Forte V. , Triglia JM , Zalzal G. Hemangioma. Head Neck. 1998;20:69-72.

82.

Mulliken JB A plea for a biologic approach to hemangiomas of infancy. Arch Dermatol. 1991;127:243-244.

83.

Tanner JL , Dechert MP , Frieden IJ Growing up with a facial hemangioma: parent and child coping with adaptation . Pediatrics. 1998;101:466-452.

84.

Zarem HA , Edgerton MT Induced resolution of cavernous hemangiomas following prednisolone therapy . Plast Reconstr Surg. 1967;39:76-83.

85.

Frost, NC , Esterly NB Successful treatment of juvenile hemangiomas with prednisone. J Pediatr. 1968;72: 351-357.

86.

Edgerton MT The treatment of hemangiomas: with special reference to the role of steroid therapy. Ann Surg. 1976;183:517-532.

87.

Kushner BJ Intralesional corticosteroid injection for infantile adnexal hemangioma. Am J Ophthalmol. 1982; 93:496-506.

88.

Kushner BJ The treatment of periorbital infantile hemangioma with intralesional corticosteroid . Plast Reconstr Surg. 1985;76:517-524.

89.

Sloan GM , Reinisch JF , Nichter LS , et al. Intralesional corticosteroid therapy for infantile hemangiomas . Plast Reconstr Surg. 1989;83:459-466.

90.

Gangopadhyay AN , Sinha CK , Gopal SC , et al. Role of steroid in childhood hemangioma: a 10 years review. Int Surg. 1997;82:49-51.

91.

Boon LM , MacDonald DM , Mulliken JB Complications of systemic corticosteroid therapy for porblematic hemangioma . Plast Reconstr Surg. 1999;104:1616-1623.

92.

Kushner BJ Hemangiomas in children. N Engl J Med. 1999 ;341:2018.

93.

Ezekowitz Rab , Mulliken JB , Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992 ;326:1456-1463.

94.

White CW , Sondheimer HM , Crouch EC , et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med. 1989;320: 1197-1200.

95.

Bauman NM , Burke DK , Smith Rjh. Treatment of massive or life-threatening hemangiomas with recombinant α 2a-interferon. Otolaryngol Head Neck Surg. 1997;117: 99-110.

96.

Hastings MM , Milot J. , Barsoum-Homsy M. , et al. Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangiomas in childhood. JAAPOS. 1997;1:226-230.

97.

Egbert JE , Nelson SC Neurologic toxicity associated with interferon alfa treatment of capillary hemangioma. JAAPOS. 1997;1:190.

98.

Castello MA , Ragni G. , Antini A. , et al. Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma. Med Pediatr Oncol. 1997;28:213-215.

99.

Tamayo L. , Ortiz DM , Orozco-Covarrubias L. , et al. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. Arch Dermatol. 1997;133:1567-1571.

100.

Barlow CF , Reiebe CJ , Mulliken JB , et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998 ;132: 527-530.

101.

Tryfonas GI , Tsikopoulos G. , Liasidou E. , et al. Conservative treatment of hemangiomas of infancy and childhood with interferon-alpha 2a. Pediatr Surg Int. 1998;13:590-593.

102.

Leaute-Labreze C. , Taieb A. Caution with regard to the efficacy of interferon alfa-2b in the treatment of giant hemangiomas. Arch Dermatol. 1998;134:1297-1298.

103.

Enjolras O. Neurotoxicity of interferon alfa in children treated for hemangiomas. J Am Acad Dermatol. 1998; 36:1037-1038.

104.

Greinwald JH , Burke DK , Bonthius DJ , et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg. 1999;125:21-27.

105.

Chang E. , Boyd A. , Nelson CC , et al. Successful treatment of infant hemangiomas with interferon α-2b . J Pediatr Hematol Oncol. 1997;19:237-244.

106.

Rosenfeld H. , Sherman R. Treatment of cutaneous and deep vascular lesions with the Nd:YAG laser. Lasers Surg Med. 1986 ;6:20-23.

107.

Apfelberg DB , Greene RA , Maser R. , et al. Results of argon laser exposure of capillary hemangiomas of infancy-preliminary report. Plast Reconstr Surg. 1981; 67:188-193.

108.

Hobby LW Further evaluation of the potential of the argon laser in the treatment of strawberry hemangiomas. Plast Reconstr Surg. 1983;71:481-485.

109.

Achauer BM , Vander Kam VM. Capillary hemangioma (strawberry mark) of infancy: comparison of argon and Nd:YAG laser treatment. Plast Reconstr Surg. 1989; 84:60-69.

110.

Apfelberg DB , Smith T. , Lash H. Preliminary report on use of the neodymium-YAG laser in plastic surgery. Lasers Surg Med. 1987;7:189-198.

111.

Preeyanont P. , Nimsakul N. The Nd:YAG laser treatment of hemangioma. J Clin Laser Med Surg. 1994;12:225-229.

112.

Anderson RR , Parrish JA Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.

113.

Garden JM , Bakus AD Laser treatment of port-wine stains and hemangiomas. Dermatol Clin. 1997;15: 373-383.

114.

Garden JM , Bakus AD , Paller AS Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis. J Pediatr. 1992;120: 555-560.

115.

Sherwood KA , Tan OT The treatment of a capillary hemangioma with the flashlamp pumped-dye laser. J Am Acad Dermatol. 1990;22:136-137.

116.

Ashinoff R. , Geronemus RG Capillary hemangiomas and treatment with the flash lamp-pulsed dye laser. Arch Dermatol. 1991;127:202-205.

117.

Scheepers JH , Quaba AA Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas? Observations based on 3 years experience. Plast Reconstr Surg. 1995;95:305-312.

118.

Tong Mcf , Van Hasselt CA The 578-nm copper vapor laser in the treatment of cavernous hemangiomas in the oral cavity. J Clin Laser Med Surg. 1994 ;12:109-110.

119.

Gregory RO Treatment of cavernous hemangiomas with intralesional ablation with YAG laser. Lasers Surg Med. 1991;11(suppl 3):66.

120.

Apfelberg DB Intralesional laser photocoagulation-steroids as an adjunct to surgery for massive hemangiomas and vascular malformations . Ann Plast Surg. 1995;35:144-148.

121.

Achauer BM , Celikoz B. , Vander Kam VM. Intralesional bare fiber laser treatment of hemangioma of infancy. Plast Reconstr Surg. 1998;101:1212-1217.

122.

Achauer BM , Chang C-J. , Vander Kam VM. Intralesional photocoagulation of periorbital hemangiomas. Plast Reconstr Surg. 1999;103:11-16.

123.

Chang C-J. , Anvari B. , Nelson JS Cryogen spray cooling for spatially selective photocoagulation of hemangiomas: a new methodology with preliminary clinical reports. Plast Reconstr Surg. 1998;102:459-463.

124.

Cremer H. Cryosurgery for hemangiomas. Pediatr Dermatol. 1998;15:410-411.

125.

Hurvitz CH , Alkalay AL , Sloninsky L. , et al. Cyclophosphamide therapy in life-threatening vascular tumors . J Pediatr. 1986;109:360-363.

126.

Kullendorf CM Efficacy of bleomycin treatment for symptomatic hemangiomas in children. Pediatr Surg Int. 1997;12:526-528.

127.

Perez J. , Pardo J. , Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 2002;41:197-199.

128.

O'Reilly MS , Boehm T. , Shing Y. , et al. Endostatin: an endogenous inhibitior of angiogenesis and tumor growth. Cell. 1997 ;88:277-285.